cancer clinical trials for Lymphoma/CLL (ONC)
21 Lymphoma/CLL (ONC) clinical trials found. View a list of all cancer clinical trial types.
-
A Phase I/II Multi-Center Study Evaluating the Safety and Efficacy of LYL314, a CD19/CD20 Dual-Targeting Chimeric Antigen Receptor T-Cell Therapy in Participants With Aggressive B-Cell Non-Hodgkin Lymphoma
Current Status: Not Open
View links and contact information related to this clinical trial -
Managed Access Program (MAP) Cohort Treatment Plan CCTL019B2003I to provide access for patients with out of specification leukapheresis product and/or out of specification manufactured tisagenlecleucel (CTL019; Kymriah®)
Current Status: Open
View links and contact information related to this clinical trial -
A Phase II, open-label, multicenter study of MB-105 in patients with CD5 positive (CD5+) relapsed / refractory T-cell lymphoma (r/r TCL)
Current Status: Open
View links and contact information related to this clinical trial -
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma (EPCORE FL-2)
Current Status: Open
View links and contact information related to this clinical trial -
A First-In-Human Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-319 in B-cell Malignancies
Current Status: Open
View links and contact information related to this clinical trial -
A Master Protocol to Evaluate the Long-Term Safety of Pirtobrutinib
Current Status: Open
View links and contact information related to this clinical trial -
Randomized, Open-label, Multicenter, Phase II Study Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vedotin Plus R-CHP in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL)
Current Status: Open
View links and contact information related to this clinical trial -
Phase II Study of Dual Targeting of CD19 and CD20 Antigens Using Sequential CD19-directed CAR-T Cells Followed by Mosunetuzumab or Glofitamab in Relapsed or Refractory Diffuse Large B-cell or Transformed Follicular Lymphomas
Current Status: Open
View links and contact information related to this clinical trial -
A Phase I Study of IM-1021 in Participants with Advanced Malignancies
Current Status: Open
View links and contact information related to this clinical trial -
Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Axicabtagene Ciloleucel
Current Status: Open
View links and contact information related to this clinical trial -
Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleucel
Current Status: Open
View links and contact information related to this clinical trial -
A Phase Ib, Open Label, Global, Multicenter, Dose Determination, Randomized Dose Expansion Study to Determine the Maximum Tolerated Dose, Assess the Safety and Tolerability, Pharmacokinetics and Preliminary Efficacy of Iberdomide (CC-220) in Combination With R-CHOP-21 and CC-99282 in Combination With R-CHOP-21 for Subjects With Previously Untreated Aggressive B-cell Lymphoma
Current Status: Open
View links and contact information related to this clinical trial -
Expanded Access Protocol (EAP) For Patients Receiving Lisocabtagene Maraleucel That Is Nonconforming For Commercial Release
Current Status: Open
View links and contact information related to this clinical trial -
Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Current Status: Open
View links and contact information related to this clinical trial -
A Phase II Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed or Refractory CD10-Negative Diffuse-Large B-Cell Lymphoma (DLBCL) and High-Grade B-Cell Lymphoma with MYC and BCL2 rearrangements (HGBCL-DH-BCL2)
Current Status: Open
View links and contact information related to this clinical trial -
Long-term Follow-up Protocol For Subjects Treated with Gene-modified T Cells
Current Status: Open
View links and contact information related to this clinical trial -
A Phase I, multicenter, oen-label study of UB-VV111 in combination with Rapamycin in relapsed or refractory (R/R) CD19+ B-Cell malignancies
Current Status: Open
View links and contact information related to this clinical trial -
An Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma
Current Status: Open
View links and contact information related to this clinical trial -
A Randomized Phase III Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma (INTERCON)
Current Status: Open
View links and contact information related to this clinical trial -
A Pilot, Randomized, Double-blind, Placebo-controlled Study using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy in Multiple Myeloma and Lymphoma: The PRIMAL Trial
Current Status: Open
View links and contact information related to this clinical trial -
An Observational Study Associating Adiponectin Signaling with Acute and Chronic Toxicity Following Pelvic Radiation
Current Status: Open
View links and contact information related to this clinical trial